What are the causes of conduction defects on an electrocardiogram (ECG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Conduction Defects on EKG

Conduction defects on ECG arise from structural cardiac disease, ischemia/infarction, electrolyte disturbances, inherited channelopathies, infiltrative diseases, and iatrogenic causes—with acute myocardial infarction and progressive degenerative disease being the most clinically significant causes affecting mortality.

Primary Etiologic Categories

Acute Ischemic and Structural Heart Disease

Myocardial infarction represents a critical cause of conduction defects with direct mortality implications. Conduction defects complicate acute MI in approximately 16% of cases and carry a graded impact on prognosis—patients with advanced bundle branch involvement have the worst outcomes 1. The location of infarction predicts the type of conduction abnormality:

  • Inferior MI: Predominantly causes atrioventricular conduction defects, including complete heart block (CHB) with narrow complex escape rhythms 2
  • Anterior MI: More commonly produces intraventricular conduction defects (bundle branch blocks) 2

The mechanism involves direct ischemic injury to conduction tissue. In the thrombolytic era, there has been a small decline in severe conduction defects, likely reflecting reduced infarct size 1.

Inherited Channelopathies and Genetic Disorders

Primary electrical diseases cause conduction abnormalities without structural heart disease 3, 4. Mutations in the SCN5A sodium channel gene cause progressive cardiac conduction system disease, either isolated or overlapping with tachyarrhythmia syndromes 4. These genetic defects affect:

  • Ion channel function (sodium, potassium channels)
  • Transcription factors controlling conduction system development (homeobox, T-box genes)
  • Gap junction proteins
  • Structural proteins (lamins)

Critical pitfall: These disorders are not identifiable at routine autopsy and require clinical ECG analysis or genetic testing for diagnosis 5.

Electrolyte Disturbances

Hyperkalemia produces a well-defined progression of conduction abnormalities: initial peaked T waves and shortened intervals progress to prolonged conduction and lethal dysrhythmias as serum potassium rises 6. The ECG provides instantaneous diagnostic information for electrolyte-induced conduction defects 7.

Inflammatory and Infiltrative Diseases

Multiple conditions produce conduction defects through myocardial infiltration or inflammation 7:

  • Myocarditis, pericarditis, endocarditis: Cause inflammatory conduction system damage
  • AIDS-related cardiac involvement
  • Infiltrative cardiomyopathies (amyloidosis, sarcoidosis)
  • Transplant rejection
  • Antineoplastic agent toxicity

Iatrogenic Causes

Following coronary artery bypass grafting, new bundle branch or fascicular block develops in 45% of patients, with third-degree AV block in 4% 8. Risk factors include:

  • Number of bypassed vessels (p<0.05)
  • Total cardiopulmonary bypass time (p<0.05)
  • Aortic cross-clamp time (p<0.05)

Importantly, 54% of these defects resolve partially or completely by hospital discharge 8.

After AV nodal ablation, 2-3% of patients suffer sudden cardiac death, likely from bradycardia-dependent prolongation of repolarization in the first 24 hours 5.

Degenerative and Age-Related Disease

Cardiac conduction disorders are common in primary care populations, especially among older individuals—prevalence reaches 27% in men and 15% in women 9. Risk factors for incident conduction disease include:

  • Older age (HR 1.25 per 5-year increase) 9
  • Male sex (incidence 8.78 vs 4.34 events/1,000 person-years in women) 9
  • Prior myocardial infarction (HR 1.39) 9
  • Hypertension and cardiovascular risk factors 9

Multisystem Disorders

Conduction defects occur as part of systemic diseases 4, 10:

  • Muscular dystrophies (Duchenne, Becker)
  • Myotonic dystrophy
  • Glycogen storage cardiomyopathy with ventricular preexcitation
  • Lamin A/C mutations causing progressive conduction disease

Clinical Implications for Mortality and Morbidity

The severity of conduction defect directly correlates with mortality risk—complete heart block involving both bundle branches carries the highest mortality, followed by bifascicular block, then isolated bundle branch blocks 1.

In acute MI specifically, mortality increases significantly when conduction defects are present, particularly in anterior infarction where the difference is highly significant (p<0.001) 2.

Diagnostic Approach

The baseline 12-lead ECG provides instantaneous diagnostic information unavailable with other tests for conduction defects 7. When evaluating conduction defects, correlate ECG findings with clinical context—look specifically for fragmented QRS, axis deviation, and ST-T changes, which associate significantly with conduction disorders and indicate myocardial ischemia or inflammation 11.

For intermittent conduction abnormalities, cardiac rhythm monitoring is essential to correlate symptoms with conduction defects, with monitor type chosen based on symptom frequency 12.

References

Research

Cardiac conduction defects.

Acta bio-medica : Atenei Parmensis, 2019

Research

Inherited conduction system abnormalities--one group of diseases, many genes.

Journal of cardiovascular electrophysiology, 2006

Research

Hyperkalemia: ECG manifestations and clinical considerations.

The Journal of emergency medicine, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.